Company Page

New York University

The NYU Langone Health Center for Psychedelic Medicine (NYU CPM) is at the forefront of exploring innovative treatments, particularly for individuals battling addiction and other illnesses. With a strong foundation in transdisciplinary research encompassing psychiatry, medicine, and preclinical studies, it drives progress across the translational spectrum from fundamental science to large-scale clinical trials. The center's interactive platforms ensure a seamless synergy between research and education, thus providing a robust infrastructure for knowledge generation, clinician and scientist training, and accurate information dissemination regarding the clinical application of psychedelics.

Education is a cornerstone of NYU CPM's mission, demonstrated by their investment in a $5M research training program aimed at nurturing junior faculty members and post-doctoral fellows to become independent investigators in Psychedelic Medicine. This initiative underscores their commitment to sustaining the momentum of the modern psychedelic renaissance, ensuring it continues to yield medical breakthroughs backed by sound science. Through a blend of research training, clinical supervision, and continuing education, NYU CPM is not only advancing the field of Psychedelic Medicine but is also playing a pivotal role in preparing medical students, psychiatry residents, and early-career researchers for the evolving landscape of psychedelic therapy.

• Teaches: Locally
• Website: https://centerforpsychedelicmedicine.org/